What CJC-1295 dosage was used in studies?
Human studies used 30, 60, or 90 micrograms per kilogram. A microgram is one-millionth of a gram; a kilogram is just over two pounds. Mice got 2 micrograms.
What amounts of CJC-1295 did researchers study?
The first human studies asked how long CJC-1295 changed two blood hormones. Researchers placed one shot just below each person's skin. The figures were 30, 60, or 90 micrograms per kilogram. Each microgram is one-millionth of a gram, and a kilogram weighs a little more than two pounds. In groups given 30 and 60 micrograms per kilogram, both hormones rose higher and remained raised longer with the larger amount [1]. The 60 and 90 microgram-per-kilogram groups kept their usual growth-hormone timing. IGF-1, a blood hormone tied to growth, was about 45% higher after a week [3]. A mouse study used 2 micrograms and compared 24-, 48-, and 72-hour gaps [4].
Human amounts rose with body weight, so the people did not all receive the same total. Researchers watched growth hormone and IGF-1 for many days [1]. In mice, 2 micrograms every 24 hours restored normal growth, while every 48 or 72 hours worked less well [4]. The mouse finding doesn't supply a safe human dose.
Online posts give fixed amounts for the shorter drug and the ipamorelin pair. Those numbers appear in personal posts and clinic material. No controlled trial in people has checked them. A fixed amount gives everyone the same total. Study amounts changed with each person's weight, so you cannot match the two kinds without more facts. These findings offer no personal dose for you.
Which CJC-1295 amounts came from people, and which came from mice?
Each human study used one shot of 30, 60, or 90 micrograms per kilogram [1][3]. Fixed online amounts did not come from those trials. The 2 microgram amount came from a mouse growth study [4]. Those papers measured IGF-1, but a mouse amount still says nothing about your dose.
How long did the drug last in the studies?
The makers designed long CJC-1295 to linger in the bloodstream. In healthy adults, 5.8 to 8.1 days passed before the amount fell by half. After repeated doses, IGF-1 remained raised for up to 28 days [1]. Blood clears the short form much faster because it lacks the albumin bond. The comparison of both forms explains what that timing means for you.
How did researchers give CJC-1295?
Most papers describe a shot placed just below the skin. Older work on the short form sometimes used a vein [1][2]. That records how the study worked; it is not a step for you to follow.
Did the papers name a body place for the shot?
No. The papers report only that the shot went below the skin [1][3]. They do not name a body place for you to use at home.
How did lab workers prepare the dry powder?
Workers added lab water to the powder and stored the mixture in the cold [1]. If swallowed, a peptide is usually broken down before much reaches your blood. These facts aren't home-use instructions.
The long CJC-1295 form in the main studies binds albumin [2]. One weight-based shot changed growth hormone and IGF-1 for several days [1][3]. Human studies haven't settled fixed amounts, weekly plans, or drug pairs. The evidence for you ends there.
What do the studies leave unknown about safety?
Which CJC-1295 amounts were tested in adults?
Healthy adults received shots holding 30 or 60 micrograms per kilogram. Workers placed each shot below the skin. One microgram is one-millionth of a gram, and body weight set each person's total. One dose changed growth hormone and IGF-1 for days [1]. The numbers describe a study, not a plan for you. The long form binds albumin, which helps it outlast the short form [2].
Only small groups took part, and follow-up was brief. Phase 1 is the first small test in people, used to watch what a drug does and look for harm. Researchers followed IGF-1 and growth hormone in healthy volunteers. A Phase 2 study then tested the drug in adults with HIV and fat around their belly organs. The study stopped for a reason the public record does not give. Afterward, the drug maker did not carry the long form into later tests. No large trial shows long-term safety or a health gain in healthy adults. CJC-1295 isn't approved as a medicine for people [1].
The papers give you no proven schedule. They give study amounts while leaving your long-term questions open. The page on safety questions and reported effects explains why that gap matters.